A chance for Pharmaco-EEG?

 "Future trials will follow an experimental medicine approach in which interventions serve not only as potential treatments, but as probes to generate information about the mechanisms underlying a disorder" declares  NIMH director Thomas Insel on his blog. It is thought that more individualized treatments in neuropsychiatric diorders, that are not only based on symptom clusters but also rely on biological information will lead to more effective treatment (see also "NIH rethinks psychiatry trials" at nature.com)

However, "the goal of this new approach is to identify new targets for treatment development, or identify therapies that directly influence disease outcome or knowledge of the disease (Nitin Gogtay, M.D., and Tom Insel, M.D., National Institute of Mental Health). The question now is, whether Pharmaco-EEG can prove its ability to enhance individual treatment. 

To shed more light on this important question, the IPEG-conference 2014 that will take place in Leipzig, Germany from the 25th to 28th of september, will dedicated a whole day, the "PERSONALIZED MEDICINE DAY" to the application of EEG for treatment predicition in neuropsychiatric disorders. The PM day will be organized by Martijn Arns, director of Brainclinics, Netherland.


Posted on 16 mrt 2014

News



EEG research and Corona Crisis 2020

Many EEG researchers are not able to perform assessment of EEG recordings in their labs due to the pandemic Covid-19 crisis. Arnaud Delorme and Scott Makeig, heads of the EEGlab platform, propose several things to do dring these hard times to prevent the lockdown of EEG research Read their hints here.

...
Read more

Abstract Book available

 The complete Abstract Book for the Zurich 2018 Meeting is available now

...
Read more

Final Program

The final program for the IPEG Meeting November 21st-25th in Zurich is ready for download HERE

...
Read more